InvestorsHub Logo
Followers 9
Posts 95
Boards Moderated 0
Alias Born 07/11/2020

Re: farrell90 post# 343408

Wednesday, 02/03/2021 12:36:56 AM

Wednesday, February 03, 2021 12:36:56 AM

Post# of 403222
I am not sure if you read this, but here is a good article in NYT lamenting about Therapeutics.

https://www.nytimes.com/2021/01/30/health/covid-drugs-antivirals.html

Some notable points:
"In February, Dr. Chanda and his colleagues began a different kind of search for a Covid-19 antiviral. They screened a library of 13,000 drugs, mixing each drug with cells and coronaviruses to see if they stopped infections.". Do you know of a drug that went through a similar process?

"Experts are particularly eager to see this data because molnupiravir may be effective in treating more than just Covid-19. In April, scientists found that the drug could also treat mice infected with other coronaviruses that cause SARS and MERS.". Do you know of any other drug that could do just that?

My questions are rhetorical, of course. But you could feel that the spirit of the article was meant for Brilacidin and IPIX, yet there was no mention of either. It was so weird when I read this yesterday. I can't wait for our trial to start.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News